Novo's Ozempic scores major win with heart-helping FDA approval. Is Rybelsus next?
admin 17th January 2020 Uncategorised 0After racing out to a fast start in its first year on the market, Novo Nordisk’s GLP-1 diabetes superstar Ozempic is already proving a darling for the Danish drugmaker. Now, a heart-helping FDA approval will likely spell even more success for the standout—and bodes well for Novo’s other much-touted diabetes launch.
More: Novo's Ozempic scores major win with heart-helping FDA approval. Is Rybelsus next?
Source: fierce